Drug Trial Radar · NCT05892718
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
Last checked: Nov 19, 2026Latest source record: Feb 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Oct 2, 2023
Primary completion
May 30, 2027
Study completion Nov 15, 2029
Sponsor
- Lead sponsor
- FBD Biologics LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jun 7, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to find out whether IV injection of HCB101 is an effective treatment for different types of advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma and what side effects (unwanted effects) may occur in subjects aged 18 years old and above.
Conditions
- Advanced Solid Tumor
- Refractory Non-Hodgkin Lymphoma
Interventions
HCB101Drug
HCB101 administered via. intravenous (IV) infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number/incidence and percentage of subjects with adverse events, including ADA.Time frame: 12 months
- Number of subjects with MTD of HCB101Time frame: 12 months
Locations
8 sites in 3 countries. Site status is shown where the registry gives one.
Hematology-Oncology Associates of the Treasure Coast
Port Saint Lucie, Florida · Recruiting
Carolina BioOncology
Huntersville, North Carolina · Recruiting
Greenville Hospital System University Medical Center (ITOR)
Greenville, South Carolina · Recruiting
UT Southwestern Medical Center
Dallas, Texas · Recruiting
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China · Recruiting
Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare
New Taipei City, Taiwan · Recruiting
National Taiwan University Hospital
Taipei, Taiwan · Recruiting
Taipei Veterans General Hospital
Taipei, Taiwan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.